H.C. Wainwright Keeps Their Buy Rating on Viridian Therapeutics (VRDN)

Tip Ranks
2025.11.05 16:16
portai
I'm PortAI, I can summarize articles.

Tsao covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Cabaletta Bio, and Hansa Biopharma AB. According to TipRanks, Tsao has an average return of 22.0% and a 53.85% success rate on recommended stocks. In addition to H.C. Wainwright, Viridian Therapeutics also received a Buy from Wedbush’s Laura Chico in a report issued today. However, on October 23, TR | OpenAI – 4o reiterated a Hold rating on Viridian Therapeutics (NASDAQ: VRDN).

Tsao covers the Healthcare sector, focusing on stocks such as Protagonist Therapeutics, Cabaletta Bio, and Hansa Biopharma AB. According to TipRanks, Tsao has an average return of 22.0% and a 53.85% success rate on recommended stocks.

In addition to H.C. Wainwright, Viridian Therapeutics also received a Buy from Wedbush’s Laura Chico in a report issued today. However, on October 23, TR | OpenAI – 4o reiterated a Hold rating on Viridian Therapeutics (NASDAQ: VRDN).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.